| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_782fb65c47e19c5a939033384d7fd0fe |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L17-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate |
2010-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4389daab761d182eda004388692aebc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8692f19f9a60891e3c554a45a978e460
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58c4e5aac774dbdf931edc53148dbce5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c82f013cd3d668a5e8a7def21b51bfd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c05b0bfb5caadda01fda50abc571596 |
| publicationDate |
2012-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120021800-A |
| titleOfInvention |
Composition for the prevention and treatment of obesity or hyperlipidemia and atherosclerotic vascular disease containing red crab as an active ingredient |
| abstract |
The present invention relates to a composition for the prevention and treatment of obesity or hyperlipidemia and atherosclerotic vascular disease containing red crab as an active ingredient. Specifically, the red crab of the present invention is a lipid in liver tissue and feces in an animal model causing hyperlipidemia. Pharmaceuticals that are useful for the prevention and treatment of obesity or hyperlipidemia and atherosclerotic vascular disease have been found to reduce content, decrease triglycerides, cholesterol, phospholipids, lipid peroxide and Hydroxyl radical content in serum, and enhance SOD activity in serum. It can be used in the composition and dietary supplements. |
| priorityDate |
2010-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |